Area of research
Epidemiology · Hepatology
Research interest
Research interests include Liver physiology and pathology, Estrogen and related hormone effects, Liver Disease Diagnosis and Treatment, and Steroid Chemistry and Biochemistry.
Young-onset hepatocellular carcinoma following double outlet right ventricle surgery without liver congestion: a case report with genetic analysis.
Remarkable response to durvalumab and tremelimumab in a patient with hepatocellular carcinoma: a case report.
Sphingosine-1-phosphate promotes liver fibrosis in metabolic dysfunction-associated steatohepatitis.
Cases of Rapid Hepatitis B Surface Antigen Reduction after COVID-19 Vaccination.
Peripheral-dominant liver fibrosis and tumor distribution in a mouse model of congestive hepatopathy.
Sphingosine-1-phosphate promotes tumor development and liver fibrosis in mouse model of congestive hepatopathy.
Iron chelator deferasirox inhibits NF-κB activity in hepatoma cells and changes sorafenib-induced programmed cell deaths.
Inhibition of CBP/β-catenin signaling ameliorated fibrosis in cholestatic liver disease.
Localizing spontaneously hemostatic colonic diverticular bleeding using VISCOCLEAR gel: A case report.
Gel immersion endoscopic mucosal resection in early gastric cancer with bleeding: A case report.
Cluster of Differentiation 44 Promotes Liver Fibrosis and Serves as a Biomarker in Congestive Hepatopathy.
Myostatin as a fibroblast-activating factor impacts on postoperative outcome in patients with hepatocellular carcinoma.
Increased Frequency of Dysfunctional Siglec-7<sup>-</sup>CD57<sup>+</sup>PD-1<sup>+</sup> Natural Killer Cells in Patients With Non-alcoholic Fatty Liver Disease.
Impact of Immune Reconstitution-Induced Hepatic Flare on Hepatitis B Surface Antigen Loss in Hepatitis B Virus/Human Immunodeficiency Virus-1 Coinfected Patients.
Blood angiopoietin-2 predicts liver angiogenesis and fibrosis in hepatitis C patients.
Kynurenine produced by indoleamine 2,3-dioxygenase 2 exacerbates acute liver injury by carbon tetrachloride in mice.
Serum soluble sialic acid-binding immunoglobulin-like lectin-7 concentration as an indicator of liver macrophage activation and advanced fibrosis in patients with non-alcoholic fatty liver disease.
Blood angiopoietin-2 predicts liver angiogenesis and fibrosis in hepatitis C patients
Bone morphogenetic protein 4 provides cancer-supportive phenotypes to liver fibroblasts in patients with hepatocellular carcinoma.
Liver disease secondary to congenital heart disease in children.
Serum milk fat globule-EGF factor 8 (MFG-E8) as a diagnostic and prognostic biomarker in patients with hepatocellular carcinoma.
Programmed cell death ligand 1 (PD-L1) blockade attenuates metastatic colon cancer growth in cAMP-response element-binding protein (CREB)-binding protein (CBP)/β-catenin inhibitor-treated livers.
Immune Determinants in the Acquisition and Maintenance of Antibody to Hepatitis B Surface Antigen in Adults After First-Time Hepatitis B Vaccination.
Whole-liver radiotherapy for diffuse liver metastases improves liver enzymes and related factors.